EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cyclic adenosine monophosphate signaling pathway in tumor-associated macrophages: molecular mechanisms and tumor immunotherapy

Yi Liu iD, Shuai Li, Wei Li, Mengting Zhou, Jie Liang, Xiaoli Liu, Xiao Wang, Yuanzhen Guo, Zhen Li, Bei Zhang iD, Luoyang Wang iD

Carcinogenesis · 07.07.2026 · 47 (3)

DOI: 10.1093/carcin/bgag026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Carcinogenesis, online erschienen am 06.05.2026. Verfasst von Yi Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical College, Qingdao University, Qingdao, Shandong 266071, PR China. Hauptthemen laut MEDLINE: Cyclic AMP, Immunotherapy, Tumor-Associated Macrophages, Neoplasms. Die Arbeit nennt 77 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated macrophages (TAMs) are the core innate immune cells in the tumor microenvironment (TME), and their phenotypic polarization and functional reprogramming determine the orientation of the tumor immune microenvironment and the efficacy of immunotherapy. As a key intracellular second messenger, cyclic adenosine monophosphate (cAMP) acts as a central hub regulating TAM function by activating two major downstream effector pathways: protein kinase A (PKA) and exchange protein directly activated by cAMP (Epac). This article systematically reviews the molecular mechanisms by which the cAMP-PKA/Epac signaling pathway regulates TAMs, the upstream regulatory factors in the TME, and targeted tumor immunotherapy strategies for this pathway. Studies have shown that cAMP mainly induces TAMs to polarize toward a protumor “M2-like phenotype” through two classical pathways: cAMP-PKA-cyclic AMP response element-binding protein (CREB) and cAMP-PKA-signal transducer and activator of transcription 3/6 (STAT3/6). Meanwhile, it enhances the immunosuppressive, proangiogenic, and profibrotic functions of TAMs via the cAMP-Epac pathway, inhibition of nuclear factor kappa-B (NF-κB) signaling, and attenuation of M1 polarization. Furthermore, lactate and hypoxia-inducible factor-1α (HIF-1α) in the TME can further activate the intracellular cAMP signaling pathway in TAMs by activating G protein–coupled receptors (GPCRs) and regulating the expression of adenylate cyclase, forming a cascade regulatory network with cAMP that exacerbates tumor immunosuppression. In addition, targeting the cAMP metabolic process, the downstream PKA pathway, and key molecules such as CREB/STAT/NF-κB can effectively reverse the “M2-like phenotype” of TAMs and restore their antitumor functions. Combination with immune checkpoint inhibitors can also significantly enhance the efficacy of tumor immunotherapy. By summarizing the core mechanisms of the cAMP-TAM regulatory axis and targeted intervention strategies, this article provides theoretical references and potential target directions for the development of novel tumor immunotherapy regimens based on TAM reprogramming.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclic AMPImmunotherapyTumor-Associated MacrophagesNeoplasmsHumansSignal TransductionTumor MicroenvironmentAnimalsCyclic AMP-Dependent Protein Kinases

Stichwörter der Autor:innen

PKA/EPAC pathwayTAMscAMPcancerimmunotherapy

Substanzen

Cyclic AMPCyclic AMP-Dependent Protein Kinases

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical College, Qingdao University, Qingdao, Shandong 266071, PR China.

ORCID-Profile: Yi Liu, Bei Zhang, Luoyang Wang

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Li, S., Li, W., Zhou, M., Liang, J., Liu, X., Wang, X., Guo, Y., Li, Z., Zhang, B., & Wang, L. (2026). Cyclic adenosine monophosphate signaling pathway in tumor-associated macrophages: molecular mechanisms and tumor immunotherapy. Carcinogenesis, 47(3). https://doi.org/10.1093/carcin/bgag026

Vancouver

Liu Y, Li S, Li W, Zhou M, Liang J, Liu X, et al. Cyclic adenosine monophosphate signaling pathway in tumor-associated macrophages: molecular mechanisms and tumor immunotherapy. Carcinogenesis. 2026;47(3). doi:10.1093/carcin/bgag026

BibTeX
@article{Liu2026,
  author = {Liu, Yi and Li, Shuai and Li, Wei and Zhou, Mengting and Liang, Jie and Liu, Xiaoli and Wang, Xiao and Guo, Yuanzhen and Li, Zhen and Zhang, Bei and Wang, Luoyang},
  title = {Cyclic adenosine monophosphate signaling pathway in tumor-associated macrophages: molecular mechanisms and tumor immunotherapy},
  journal = {Carcinogenesis},
  year = {2026},
  volume = {47},
  number = {3},
  doi = {10.1093/carcin/bgag026}
}
Kostenlos starten →